Taipei, Taiwan

Yu-Cheng Lee

This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Optoma Corporation, Wistron Corporation. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu-Cheng Lee. Retrieved from https://idiyas.com/inventor/yu-cheng-lee-0iaqpl74

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Yu-Cheng Lee: Revolutionizing Technology in New Taipei

Introduction: Yu-Cheng Lee is a visionary inventor based in New Taipei, Taiwan, known for his groundbreaking contributions to the field of technology.

Latest Patents: Lee holds several patents in the areas of artificial intelligence, robotics, and renewable energy, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Yu-Cheng Lee has worked with leading tech companies to develop cutting-edge solutions that have redefined industries and improved the quality of life for many.

Collaborations: Throughout his career, Lee has collaborated with top researchers, engineers, and scientists globally, fostering a culture of innovation and knowledge exchange that has led to remarkable advancements in technology.

Conclusion: Yu-Cheng Lee's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in New Taipei and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…